| scholarly article | Q13442814 |
| P50 | author | Peiguo Yang | Q57321777 |
| Ryan G Walker | Q60371628 | ||
| Claudio Macias-Trevino | Q86532989 | ||
| Francesco Loffredo | Q43080244 | ||
| Thomas B. Thompson | Q55189411 | ||
| P2093 | author name string | Richard T Lee | |
| Miook Cho | |||
| Amy J Wagers | |||
| Yick W Fong | |||
| Jill Goldstein | |||
| Tommaso Poggioli | |||
| Ana Vujic | |||
| Aysu Uygur | |||
| James R Pancoast | |||
| Rachel M Tandias | |||
| Emilia Gonzalez | |||
| P2860 | cites work | Regulation of myostatin activity and muscle growth | Q24555817 |
| Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure | Q24646933 | ||
| Autoregulation of neurogenesis by GDF11 | Q28204949 | ||
| Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member | Q28237287 | ||
| Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle | Q28239514 | ||
| GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration | Q28262319 | ||
| GDF11 does not rescue aging-related pathological hypertrophy | Q28267548 | ||
| Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy | Q28290417 | ||
| GDF11 modulates NGN3+ islet progenitor cell number and promotes beta-cell differentiation in pancreas development | Q28293930 | ||
| Molecular aging and rejuvenation of human muscle stem cells | Q30494635 | ||
| Association of growth differentiation factor 11/8, putative anti-ageing factor, with cardiovascular outcomes and overall mortality in humans: analysis of the Heart and Soul and HUNT3 cohorts | Q30690645 | ||
| Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators | Q33642619 | ||
| METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11. | Q34447001 | ||
| Highly specific detection of myostatin prodomain by an immunoradiometric sandwich assay in serum of healthy individuals and patients | Q35049028 | ||
| Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay | Q35853649 | ||
| TGFβ signaling and cardiovascular diseases | Q37976673 | ||
| Reduced Circulating GDF11 Is Unlikely Responsible for Age-Dependent Changes in Mouse Heart, Muscle, and Brain | Q40537791 | ||
| Quantitative estimations of five classes of immunoglobulin in inbred mouse strains | Q45353578 | ||
| Alterations in the TGFbeta signaling pathway in myogenic progenitors with age. | Q52085363 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 29-37 | |
| P577 | publication date | 2015-10-21 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Circulating Growth Differentiation Factor 11/8 Levels Decline With Age | |
| P478 | volume | 118 |
| Q47675142 | * The Impact of Age on Skeletal Muscle Progenitor Cell Survival and Fate After Injury |
| Q33630598 | Activin A more prominently regulates muscle mass in primates than does GDF8. |
| Q58769040 | Activin subfamily peptides predict chronological age in humans |
| Q64085536 | Age-Associated Changes in the Immune System and Blood⁻Brain Barrier Functions |
| Q34520504 | Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation |
| Q96136852 | Cellular and Molecular Biomarkers Indicate Premature Aging in Pseudoxanthoma Elasticum Patients |
| Q93081979 | Circulating Concentrations of GDF11 are Positively Associated with TSH Levels in Humans |
| Q40100992 | Circulating Concentrations of Growth Differentiation Factor 11 Are Heritable and Correlate With Life Span |
| Q64063995 | Circulating GDF11 levels are decreased with age but are unchanged with obesity and type 2 diabetes |
| Q90331275 | Circulating anti-geronic factors from heterochonic parabionts promote vascular rejuvenation in aged mice: transcriptional footprint of mitochondrial protection, attenuation of oxidative stress, and rescue of endothelial function by young blood |
| Q53688947 | Crystal structure of human GDF11. |
| Q92649688 | Effects of Exercise Training on Growth and Differentiation Factor 11 Expression in Aged Mice |
| Q52726177 | Endoplasmic Reticulum Stress Induces Myostatin High Molecular Weight Aggregates and Impairs Mature Myostatin Secretion. |
| Q38710240 | Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting. |
| Q90282613 | Exogenous GDF11, but not GDF8, reduces body weight and improves glucose homeostasis in mice |
| Q26741143 | Extracellular RNA in aging |
| Q90668206 | GDF11 Decreases Pressure Overload-Induced Hypertrophy, but Can Cause Severe Cachexia and Premature Death |
| Q55220754 | GDF11 Modulates Ca2+-Dependent Smad2/3 Signaling to Prevent Cardiomyocyte Hypertrophy. |
| Q40630512 | GDF11 Protects against Endothelial Injury and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E-Null Mice |
| Q37636568 | GDF11 administration does not extend lifespan in a mouse model of premature aging |
| Q37282297 | GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation |
| Q37310579 | GDF11 improves tubular regeneration after acute kidney injury in elderly mice |
| Q58765030 | GDF11 induces differentiation and apoptosis and inhibits migration of C17.2 neural stem cells via modulating MAPK signaling pathway |
| Q88582376 | GDF11 induces kidney fibrosis, renal cell epithelial-to-mesenchymal transition, and kidney dysfunction and failure |
| Q37022107 | GDF11/BMP11 activates both smad1/5/8 and smad2/3 signals but shows no significant effect on proliferation and migration of human umbilical vein endothelial cells |
| Q92055451 | Gdf11 gene transfer prevents high fat diet-induced obesity and improves metabolic homeostasis in obese and STZ-induced diabetic mice |
| Q43192139 | Getting Old through the Blood: Circulating Molecules in Aging and Senescence of Cardiovascular Regenerative Cells |
| Q38614247 | Growth Differentiation Factor 11 does not Mitigate the Lethal Effects of Total-Abdominal Irradiation |
| Q59333076 | Growth Differentiation Factor 11 treatment leads to neuronal and vascular improvements in the hippocampus of aged mice |
| Q92632257 | Growth differentiation factor 11 (GDF11) has pronounced effects on skin biology |
| Q38812346 | Interorgan Communication Pathways in Physiology: Focus on Drosophila |
| Q34520509 | Is Growth Differentiation Factor 11 a Realistic Therapeutic for Aging-Dependent Muscle Defects? |
| Q37033031 | Molecular circuitry of stem cell fate in skeletal muscle regeneration, ageing and disease |
| Q26745904 | Molecular studies of exercise, skeletal muscle, and ageing |
| Q51838662 | Muscle Stem Cells: A Model System for Adult Stem Cell Biology. |
| Q51269030 | Myostatin propeptide mutation of the hypermuscular Compact mice decreases the formation of myostatin and improves insulin sensitivity. |
| Q54262478 | Neonatal Systemic AAV-Mediated Gene Delivery of GDF11 Inhibits Skeletal Muscle Growth. |
| Q92082182 | Neuroprotective Potential of GDF11: Myth or Reality? |
| Q89384861 | No longer going to waste |
| Q38884029 | Pathways for salvage and protection of the heart under stress: novel routes for cardiac rejuvenation. |
| Q90379140 | Plasma growth differentiation factors 8 and 11 levels in cats with congestive heart failure secondary to hypertrophic cardiomyopathy |
| Q37020043 | Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease. |
| Q38671328 | Quantitation of circulating GDF-11 and β2-MG in aged patients with age-related impairment in cognitive function |
| Q42552906 | Questions and Answers About Myostatin, GDF11, and the Aging Heart |
| Q60958631 | Regenerative Capacity of Endogenous Factor: Growth Differentiation Factor 11; a New Approach of the Management of Age-Related Cardiovascular Events |
| Q38981139 | Rejuvenating Strategies for Stem Cell-Based Therapies in Aging |
| Q92801370 | Rejuvenating Strategies of Tissue-specific Stem Cells for Healthy Aging |
| Q58088824 | Relationship of Circulating Growth/Differentiation Factors 8 and 11 and Their Antagonists as Measured Using Liquid Chromatography-Tandem Mass Spectrometry with Age and Skeletal Muscle Strength in Healthy Adults |
| Q30234641 | Role of circulating factors in cardiac aging. |
| Q44296589 | Role of growth differentiation factor 11 in development, physiology and disease |
| Q93067806 | Sarcopenia: Aging-Related Loss of Muscle Mass and Function |
| Q36987459 | Serum Levels of Growth Differentiation Factor 11 Are Independently Associated with Low Hemoglobin Values in Hemodialysis Patients |
| Q100737149 | Similar sequences but dissimilar biological functions of GDF11 and myostatin |
| Q31813087 | Structural basis for potency differences between GDF8 and GDF11. |
| Q34552864 | Supraphysiological levels of GDF11 induce striated muscle atrophy |
| Q38625964 | Systemic Problems: A perspective on stem cell aging and rejuvenation |
| Q51069694 | Targeted myocardial delivery of GDF11 gene rejuvenates the aged mouse heart and enhances myocardial regeneration after ischemia-reperfusion injury. |
| Q33720405 | The Role of the Molecular Clock in Skeletal Muscle and What It Is Teaching Us About Muscle-Bone Crosstalk. |
| Q87829005 | The TGFβ superfamily in cardiac dysfunction |
| Q91555631 | The biology of the extracorporeal vasculature of Botryllus schlosseri |
| Q39313687 | The brain, sirtuins, and ageing |
| Q39145772 | The versatility and paradox of GDF 11. |
| Q39682345 | Treatment with rGDF11 does not improve the dystrophic muscle pathology of mdx mice |
| Q45073569 | Tumor-Suppressor Inactivation of GDF11 Occurs by Precursor Sequestration in Triple-Negative Breast Cancer |
| Q90854384 | Turning back time with emerging rejuvenation strategies |
| Q91825527 | Variation in zygotic CRISPR/Cas9 gene editing outcomes generates novel reporter and deletion alleles at the Gdf11 locus |
| Q26770845 | When stem cells grow old: phenotypes and mechanisms of stem cell aging |
Search more.